.

Deeper Knowledge, Faster

  • Plan your formulary budget
  • Predict branded drug patent expiration
  • Uncover prior art in expired and abandoned patents

► See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

QuintilesIMS
Mallinckrodt
UBS
Queensland Health
Federal Trade Commission
Argus Health
Chubb
Teva
Merck
Boehringer Ingelheim

Generated: July 25, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 017768

« Back to Dashboard
NDA 017768 describes HIBICLENS, which is a drug marketed by Molnlycke Hlth and is included in two NDAs. It is available from three suppliers. Additional details are available on the HIBICLENS profile page.

The generic ingredient in HIBICLENS is chlorhexidine gluconate. There are fifty-seven drug master file entries for this compound. Fifty-nine suppliers are listed for this compound. Additional details are available on the chlorhexidine gluconate profile page.

Summary for NDA: 017768

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Dental and Oral Agents
Formulation / Manufacturing:see details

Suppliers and Packaging for NDA: 017768

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
HIBICLENS
chlorhexidine gluconate
SOLUTION;TOPICAL 017768 NDA Molnlycke Health Care 0234-0575 0234-0575-40 118 mL in 1 BOTTLE (0234-0575-40)
HIBICLENS
chlorhexidine gluconate
SOLUTION;TOPICAL 017768 NDA Molnlycke Health Care 0234-0575 0234-0575-17 50 PACKET in 1 CARTON (0234-0575-17) > 15 mL in 1 PACKET

Summary for product number 001

Active Rx/OTC/Discontinued:OTCDosage:SOLUTION;TOPICALStrength4%
Approval Date:Approved Prior to Jan 1, 1982TE:RLD:Yes

Expired Orange Book Patents for NDA: 017768

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Molnlycke Hlth
HIBICLENS
chlorhexidine gluconate
SOLUTION;TOPICAL017768-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
Molnlycke Hlth
HIBICLENS
chlorhexidine gluconate
SOLUTION;TOPICAL017768-001Approved Prior to Jan 1, 1982► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.



Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Fish and Richardson
Moodys
Express Scripts
Fuji
Healthtrust
Cerilliant
Queensland Health
Accenture
Baxter
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted Heap | Mobile and Web Analytics

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot